Cargando…

Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study

BACKGROUND: This study aimed to investigate risk factors for colonisation with extensively drug-resistant P. aeruginosa (XDR-PA) in immunocompromised patients and to build a clinical risk score (CRS) based on these results. METHODS: We conducted a matched case–control study with 31 cases and 93 cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Willmann, Matthias, Klimek, Anna M, Vogel, Wichard, Liese, Jan, Marschal, Matthias, Autenrieth, Ingo B, Peter, Silke, Buhl, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266216/
https://www.ncbi.nlm.nih.gov/pubmed/25490897
http://dx.doi.org/10.1186/s12879-014-0650-9
_version_ 1782348991096160256
author Willmann, Matthias
Klimek, Anna M
Vogel, Wichard
Liese, Jan
Marschal, Matthias
Autenrieth, Ingo B
Peter, Silke
Buhl, Michael
author_facet Willmann, Matthias
Klimek, Anna M
Vogel, Wichard
Liese, Jan
Marschal, Matthias
Autenrieth, Ingo B
Peter, Silke
Buhl, Michael
author_sort Willmann, Matthias
collection PubMed
description BACKGROUND: This study aimed to investigate risk factors for colonisation with extensively drug-resistant P. aeruginosa (XDR-PA) in immunocompromised patients and to build a clinical risk score (CRS) based on these results. METHODS: We conducted a matched case–control study with 31 cases and 93 controls (1:3). Cases were colonised with XDR-PA during hospitalisation. Independent risk factors were determined using a three step conditional logistic regression procedure. A CRS was built with respect to the corresponding risk fraction of each risk factor, and its discriminatory power was estimated by receiver operating characteristic (ROC) analysis. RESULTS: The presence of a central venous catheter (OR 7.41, P = 0.0008), the presence of a urinary catheter (OR 21.04, P < 0.0001), CRP > 10 mg/dl (OR 7.36, P = 0.0015), and ciprofloxacin administration (OR 5.53, P = 0.025) were independent risk factors. The CRS exhibited a high discriminatory power, defining a high risk population with an approximately fourteen times greater risk for XDR-PA colonisation. CONCLUSIONS: Unnecessary use of antibiotics, particularly ciprofloxacin should be avoided, and a high standard of infection control measures must be achieved when using medical devices. A CRS can be used for adaptation of the active screening culture policy to the local setting. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-014-0650-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4266216
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42662162014-12-16 Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study Willmann, Matthias Klimek, Anna M Vogel, Wichard Liese, Jan Marschal, Matthias Autenrieth, Ingo B Peter, Silke Buhl, Michael BMC Infect Dis Research Article BACKGROUND: This study aimed to investigate risk factors for colonisation with extensively drug-resistant P. aeruginosa (XDR-PA) in immunocompromised patients and to build a clinical risk score (CRS) based on these results. METHODS: We conducted a matched case–control study with 31 cases and 93 controls (1:3). Cases were colonised with XDR-PA during hospitalisation. Independent risk factors were determined using a three step conditional logistic regression procedure. A CRS was built with respect to the corresponding risk fraction of each risk factor, and its discriminatory power was estimated by receiver operating characteristic (ROC) analysis. RESULTS: The presence of a central venous catheter (OR 7.41, P = 0.0008), the presence of a urinary catheter (OR 21.04, P < 0.0001), CRP > 10 mg/dl (OR 7.36, P = 0.0015), and ciprofloxacin administration (OR 5.53, P = 0.025) were independent risk factors. The CRS exhibited a high discriminatory power, defining a high risk population with an approximately fourteen times greater risk for XDR-PA colonisation. CONCLUSIONS: Unnecessary use of antibiotics, particularly ciprofloxacin should be avoided, and a high standard of infection control measures must be achieved when using medical devices. A CRS can be used for adaptation of the active screening culture policy to the local setting. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-014-0650-9) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-10 /pmc/articles/PMC4266216/ /pubmed/25490897 http://dx.doi.org/10.1186/s12879-014-0650-9 Text en © Willmann et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Willmann, Matthias
Klimek, Anna M
Vogel, Wichard
Liese, Jan
Marschal, Matthias
Autenrieth, Ingo B
Peter, Silke
Buhl, Michael
Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study
title Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study
title_full Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study
title_fullStr Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study
title_full_unstemmed Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study
title_short Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study
title_sort clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant pseudomonas aeruginosa in a haematological patient population: a matched case control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266216/
https://www.ncbi.nlm.nih.gov/pubmed/25490897
http://dx.doi.org/10.1186/s12879-014-0650-9
work_keys_str_mv AT willmannmatthias clinicalandtreatmentrelatedriskfactorsfornosocomialcolonisationwithextensivelydrugresistantpseudomonasaeruginosainahaematologicalpatientpopulationamatchedcasecontrolstudy
AT klimekannam clinicalandtreatmentrelatedriskfactorsfornosocomialcolonisationwithextensivelydrugresistantpseudomonasaeruginosainahaematologicalpatientpopulationamatchedcasecontrolstudy
AT vogelwichard clinicalandtreatmentrelatedriskfactorsfornosocomialcolonisationwithextensivelydrugresistantpseudomonasaeruginosainahaematologicalpatientpopulationamatchedcasecontrolstudy
AT liesejan clinicalandtreatmentrelatedriskfactorsfornosocomialcolonisationwithextensivelydrugresistantpseudomonasaeruginosainahaematologicalpatientpopulationamatchedcasecontrolstudy
AT marschalmatthias clinicalandtreatmentrelatedriskfactorsfornosocomialcolonisationwithextensivelydrugresistantpseudomonasaeruginosainahaematologicalpatientpopulationamatchedcasecontrolstudy
AT autenriethingob clinicalandtreatmentrelatedriskfactorsfornosocomialcolonisationwithextensivelydrugresistantpseudomonasaeruginosainahaematologicalpatientpopulationamatchedcasecontrolstudy
AT petersilke clinicalandtreatmentrelatedriskfactorsfornosocomialcolonisationwithextensivelydrugresistantpseudomonasaeruginosainahaematologicalpatientpopulationamatchedcasecontrolstudy
AT buhlmichael clinicalandtreatmentrelatedriskfactorsfornosocomialcolonisationwithextensivelydrugresistantpseudomonasaeruginosainahaematologicalpatientpopulationamatchedcasecontrolstudy